Skip to main content
Premium Trial:

Request an Annual Quote

Korean NIH Partners with Affy for Genome-Wide Association Studies

NEW YORK, March 8 (GenomeWeb News) - Korea's National Institute of Health will use Affymetrix's Human 500K Mapping Set to perform genome-wide association studies in several disease areas, including diabetes, hypertension, and metabolic syndrome, Affy said today.


According to Affymetrix, the Korean NIH will work with academic and industry partners to generate more than 10 billion individual genotypes from 20,000 human DNA samples to help identify the genetic causes of these diseases using Affy's technology.


Financial details of the agreement were not discussed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.